Previous 10 | Next 10 |
PRS-220, an oral inhaled Anticalin protein targeting CTGF, a fully proprietary drug candidate for respiratory disease, is being developed as a local treatment for idiopathic pulmonary fibrosis Grant to enable the evaluation of PRS-220 for the treatment of post-COVID-19-related pulmonary f...
15 Penny Stocks For Your Watchlist Right Now Are you looking for the best penny stocks to buy right now? Well, before doing so, let’s take a step back. Buying penny stocks in 2021 is all about having a thorough understanding of what’s making the market move. Right now,...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Pieris Pharmaceuticals, Inc. Receives Orphan Drug Designation for Cinrebafusp Alfa ” Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) climbed over 5% in pre...
Gainers: Kaleido Biosciences (KLDO) +15%, Pieris Pharmaceuticals (PIRS) +14%, Arcus Biosciences (RCUS) +14%, Compugen (CGEN) +14%, Atossa Therapeutics (ATOS) +14%.Losers: Portage Biotech (PRTG) -23%, Rite Aid (RAD) -14%, 4D Mole...
Why do some stocks trade in the single digits? Often a stock is cheap because it's a loser company, and the market has priced it accordingly. It's always dangerous investing in subpar penny stocks. On the other hand, the market is not omniscient. Sometimes stocks you want to own are sur...
Pieris Pharmaceuticals shares rise ([[PIRS]] +8.5%) after the U.S. FDA granted orphan drug designation to cinrebafusp alfa (PRS-343) for the treatment of HER2-high and HER2-low expressing gastric cancers.FDA grants orphan drug designation to promote the development of a drug that targets a co...
BOSTON, MA / ACCESSWIRE / June 24, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for respiratory diseases, cancer, and other indications, today an...
3 Biotech Penny Stocks to Watch in July 2021 Biotech penny stocks have been on fire over the past year and a half. While this began during the pandemic and the resulting focus on biotech companies working on a Covid treatment, it is now much broader. In June of 2021, investors are searc...
3 Penny Stocks to Watch Today As we come to the end of another week in June, penny stocks continue to heat up. This is marked by higher than average volume, and large intraday gains with certain penny stocks . As Covid cases decline around the world and vaccine rates hit all-time hi...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks inched higher Friday to finish in the green for the week, as optimism over the post-pandemic U.S. economic recovery drove the investme...
News, Short Squeeze, Breakout and More Instantly...
Pieris Pharmaceuticals Inc. Company Name:
PIRS Stock Symbol:
NASDAQ Market:
Pieris Pharmaceuticals Inc. Website:
Proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for serious, rare genetic skin diseases for which there are no FDA-approved therapies Combined company is expected to have approximately $80.5 millio...
2024-07-17 02:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...